Cargando…
Epigenetic silencing of ZCCHC10 by the lncRNA SNHG1 promotes progression and venetoclax resistance of acute myeloid leukemia
The gene encoding the tumor suppressor p53 is the most frequently mutated gene in cancers. However, p53 mutation is rare in acute myeloid leukemia (AML), and p53 is inactivated predominantly by aberrant expression of p53 regulators (such as MDM2). A previous study by the authors revealed that the ZC...
Autores principales: | Zhou, Hao, Zhang, Qing, Huang, Wei, He, Chunping, Zhou, Chang, Zhou, Jianlin, Ning, Yichong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10147099/ https://www.ncbi.nlm.nih.gov/pubmed/37052262 http://dx.doi.org/10.3892/ijo.2023.5512 |
Ejemplares similares
-
ZCCHC10 suppresses lung cancer progression and cisplatin resistance by attenuating MDM2-mediated p53 ubiquitination and degradation
por: Ning, Yichong, et al.
Publicado: (2019) -
miR-621 May Suppress Cell Proliferation via Targeting lncRNA SNHG10 in Acute Myeloid Leukemia
por: Xiao, Shishan, et al.
Publicado: (2021) -
LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer
por: Zhang, Mingkun, et al.
Publicado: (2021) -
LncRNA SNHG6 Silencing Could Arrest Progression of High Grade Colorectal Cancers
por: Jafari-Oliayi, Amin, et al.
Publicado: (2022) -
LncRNA SNHG1: role in tumorigenesis of multiple human cancers
por: Zeng, Huang, et al.
Publicado: (2023)